I like the idea of cost plus to manufacture the drug as you can't lose on that since cost has all your overheads in it for the manufacturing part, and then royalties on the drug from MNK which I do believe we do not know what % as of yet? Win/Win situation great deal.
News 
Market Data 
Discover 
AI
